期刊文献+

单纯收缩期高血压患者血清晚期糖基化终产物与血管功能的关系 被引量:4

Relationship between Advanced Glycation End Products and Vascular Function in Patients with Isolated Systolic Hypertension
原文传递
导出
摘要 目的探讨晚期糖基化终末产物(AGEs)与血流介导的内皮依赖性血管舒张功能(FMD)间的关系及其致血管功能异常的作用。方法选择单纯收缩期高血压(ISH)患者120例作为ISH组,双期高血压患者120例作为双期高血压(DH)组,年龄配对的健康人群70例作为正常对照组,采用日本科林公司生产的VP1000动脉硬化检测仪测定颈股动脉脉搏波传导速度(cfPWV),超声技术测定FMD,ELISA检测受试者外周血清中AGEs和内皮素1,Griess法测定外周血中一氧化氮含量。结果ISH组的cfPWV、AGEs、内皮素1高于DH组及正常对照组(P<0.05);ISH组及DH组FMD、一氧化氮低于正常对照组(P<0.05),而FMD、一氧化氮在ISH组及DH组间差异无统计学意义;AGEs与cfPWV、内皮素1呈正相关(r=0.525,P<0.01;r=0.863,P<0.01);AGEs与FMD、一氧化氮呈负相关(r=-0.635,P<0.01;r=-0.669,P<0.01);多元逐步回归分析显示AGEs、cfPWV是FMD的危险因素。结论AGEs是导致血管功能异常的危险因素,可能在ISH的发生发展过程中起一定作用。 Objective To investigate the correlation between advanced glycation end products (AGEs) and endothelium dysfunction defined by flow-mediated vasodilatation (FMD) and in patients with isolated systolic hypertension.MethodsOne hundred and twenty patients with isolated systolic hypertension (ISH), 120 patients with systolic-diastolic hypertension (DH) and 70 aged-matched NT (normotension control) subjects were recruited.Pulse wave velocity (PWV) and FMD were determined.Serum AGEs, ET-1 were measured by ELISA, and NO by Griess' method.ResultsThe PWV, AGEs and ET-1 were significantly higher in ISH patients compared with NT controls and DH patients, while FMD and NO in ISH patients and DH patients were markedly lower than those in NT controls.AGEs was significantly positively correlated with PWV and ET-1 (r=0.525, P〈0.01; r=0.863, P〈0.01), but negatively correlated with FMD and NO (r=-0.635, P〈0.01; r=-0.669, P〈0.01).Multiple linear regression analysis showed AGEs, cfPWV were risk factors for impaired FMD.ConclusionAGEs was the risk factor of endothelium dysfunction, and may be involved in the development of ISH.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2010年第2期148-152,共5页 Chinese Journal of Hypertension
关键词 晚期糖基化终产物 血流介导的内皮依赖性血管舒张功能 脉搏波传导速度 单纯收缩期高血压 Advanced glycation end products Flow-mediated vasodilatation Pulse wave velocity Isolated systolic hypertension
  • 相关文献

参考文献11

  • 1Zieman SJ, Kass DA. Advanced glycation endproduct cross-linking in the cardiovascular system: potential therapeutic target for cardiovascular disease[J]. Drugs, 2004,64 (5) : 459-470.
  • 2曾平,许顶立,李针,赖文岩,任昊.晚期糖基化终产物对心肌细胞细胞周期和凋亡的影响[J].第一军医大学学报,2003,23(1):9-11. 被引量:28
  • 3Semba RD, Najjar SS, Sun K, et al. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults[J]. Am J Hypertens, 2009,22(1) :74-79.
  • 4McNulty M, Mahmud A, Feely J. Advanced glycation end-products and arterial stiffness in hypertension[J]. Am J Hypertens, 2007,20(3) :242-247.
  • 5Wallace SM, Yasmin, McEniery CM, et al. Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction[J]. Hypertension,2007,50(1) :228-233.
  • 6庞战军.Griess试剂法-自由基医学研究方法[M],北京,人民卫生出版社:224-226.
  • 7Soro-Paavonen A, Watson AM, Li J, et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes [J]. Diabetes, 2008, 57 (9) : 2461-2469.
  • 8Jandeleit-Dahm K, Cooper ME. The role of AGEs in cardiovascular disease[J]. Curr Pharm Des, 2008,14 (10) :979-986.
  • 9吴雅利,雷梦觉,刘秋玲,涂燕平,龚爱斌.单纯收缩期高血压病人年龄与血管内皮功能对大动脉僵硬度的影响[J].中华高血压杂志,2008,16(8):704-706. 被引量:7
  • 10Yan SF, Ramasamy RH, Naka YF, et al. Glycation,inflammation,and RAGE: a scaffold for the macrovascular complications of diabetes and beyond[J]. Circ Res,2003,93(12) : 1159-1169.

二级参考文献40

  • 1[1]Bierhaus A, Hofmann MA, Ziegler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept[J]. Cardiovasc Res, 1998, 37(3):586-600.
  • 2[5]Wang J, Walsh K. Resistance to apoptosis conferred by cdk inhibitors during myocyte differentiation[J]. Science, 1996, 273 (5273): 359-61.
  • 3[6]Wells-knecht K J, Brinkmann E. New biomarkers of Maillard reaction damage to protein[J]. Nephrol Dial Transplant, 1996, 1 l(Suppl 5):41-7.
  • 4[7]Min C, Kang E, Yu SH, et al. Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells[J]. Diabetes Res Clin Pract, 1999,46(3): 197-202.
  • 5[8]Yamagishi S, Inagaki Y, Okamoto T, et al. Advanced glycation end products-induced apoptosis of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human cultured messangial cells[J]. J Biol Chem, 2002, 277(23): 20309-15.
  • 6[9]Saraste A, Pulkki K, Kallajoki M, et al. Apoptosis in hunan acute myocardial infarction[ J ]. Circulation, 1997, 95(2): 320-3.
  • 7[10]Olivetti C, Abbi R, Quaini F, et al. Apoptosis in the failing hman heart[J]. N Engl J Med, 1997, 336(16): 1131-41.
  • 8[11]Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes[J]. Cir Res, 1994, 75(3): 426-33.
  • 9[12]Turner NA, Xia F, Azhar G, et al. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells[J]. J Mol Cell Cardiol,1998, 30(9): 1789-801.
  • 10[13]Sabbah HN, Sharov VG. Apoptosis in heart failure [ J ]. Prog Cardiolvasc Dis, 1998, 40(6): 549-62.

共引文献51

同被引文献64

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2052
  • 2冯海波,庄惠君,孙宁玲,喜杨,纪立农.不同血糖水平糖尿病患者动脉弹性指数的变化[J].中华高血压杂志,2007,15(7):575-578. 被引量:19
  • 3中国高血压防治指南修订委员会.中国高血压防治指南.中华心血管病杂志,2010,39:579-616.
  • 4Ziem an SJ, Kass DA. Advanced glycation endproduct cross- linking in the cardiovascular system:potential therapeutic tar- get for cardiovascular disease. Drugs,2004,64:459 -470.
  • 5Semba RD, Najjar SS, Sun K, et al. Serum carboxymethyl ly- sine,an advanced glycation end product,is associated with in- creased aortic pulse wave velocity in adults. Am J Hypertens,2009,22:74- 79.
  • 6McNulty M, Mahmud A, Feely J. Advanced glycation end- products and arterial stiffness in hypertension. Am J Hyper- tens,2007,20:242-247.
  • 7Hartog JW, van de Wal RM, Schalkwijk CG, et al. Advanced glycation end-products,anti-hypertensive treatment and dias tolic function in patients with hypertension and diastolic dys- function. Eur J Heart Fail, 2010,12:397- 403.
  • 8Tanaka K, Tani Y, Asai J, et al. Skin autofluorescence is asso- ciated with severity of vascular complications in Japanese pa tients with type 2 diabetes. Diabet Med,2012,29:492- 500.
  • 9Tanaka K, Tani Y, Asai J, et al. Skin autofluorescence is asso- ciated with renal function and cardiovascular diseases in pre- dialysis chronic kidney disease patients. Nephrol Dial Trans- plant, 2011,26 : 214-220.
  • 10Bierhaus A, Hofmann MA, Ziegler R,et al. AGE and their in-teraction with AGE-receptors in vascular disease and diabetesmellitus: the AGE concept[J]. Cardiovasc Res, 1998,37(3) : 586-600.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部